Our work
Our specific impact goals are to:
- Increase access to health interventions in countries with high burdens of infectious diseases through the generation and use of high-quality research.
- Accelerate the development of innovative tools, solutions and implementation strategies essential for disease control and elimination through research and partnership.
- Build a critical mass of researchers in disease-affected countries who can conduct, lead and further develop research through training and mentorship.
- Engage a broad global community to facilitate the role of research for development, and advocate for the use of high quality evidence to inform policy.
Recent news
AllRecent publications
All >>
6 September 2011
Use of interferon-y (inteferon-gama) release assays (IGRAs) in tuberculosis control in low- and middle-income...
Research over the past decade has resulted in the development of two commercial interferon-gamma release assays (IGRAs). Both assays work on the principle...
15 February 2011
Commercial serodiagnostic tests for diagnosis of tuberculosis
An antibody detection-based diagnostic test in a user-friendly format could potentially replace microscopy and extend tuberculosis diagnosis to lower levels...
6 September 2010
Evidence for treatment policy for HIV-infected tuberculosis patients : annual report 2009
This business line aims to produce the evidence needed to drive the development and delivery of TB/HIV care guidelines in disease-endemic settings. Despite...
1 June 2010
TDR annual report 2009
The TDR annual report describes key projects and achievements during 2009. The report is divided into three parts. The first introduces TDR and summarizes some...
Neglected tropical diseases (NTDs) generate morbidity and mortality in poverty-stricken populations. They are regarded as a public health priority for...
22 December 2009
Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 2 (2009)
This summary presents an overview of the results of the first and second rounds of WHO product testing of malaria antigen-detecting RDTs completed in 2008...